EQT
47
13
SJM
17
5
ROST
60
3
LEN
21
3
AN
49
2
AES
47
4
MTB
38
4
GM
55
6
PNC
48
6
VMC
41
2
DFS
64
4
LNC
28
3
ADP
57
2
HBI
53
4
KMI
69
8
ZBH
69
15
ICE
53
5
PFE
37
4
HSIC
42
2
VTR
44
4
EQT
47
13
SJM
17
5
ROST
60
3
LEN
21
3
AN
49
2
AES
47
4
MTB
38
4
GM
55
6
PNC
48
6
VMC
41
2
DFS
64
4
LNC
28
3
ADP
57
2
HBI
53
4
KMI
69
8
ZBH
69
15
ICE
53
5
PFE
37
4
HSIC
42
2
VTR
44
4
Financhill
Back

MoonLake Immunotherapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
30

MLTX
MoonLake Immunotherapeutics

Last Price:
$52.27
Seasonality Move:
32.39%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
30
MoonLake Immunotherapeutics (MLTX) is a Sell

Is MoonLake Immunotherapeutics a Buy, Sell or Hold?

  • The current MoonLake Immunotherapeutics [MLTX] share price is $52.17. The Score for MLTX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • MLTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MLTX Stock Price Chart

What is MoonLake Immunotherapeutics's stock price today?

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

MLTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 49.27 Sell
Chaikin Money Flow: 1487 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.72 - 54.62) Sell
Bollinger Bands (100): (46.36 - 52.96) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

MLTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.03 Sell
20-day SMA: 53.42 Sell
50-day SMA: 50.78 Buy
200-day SMA: 46.72 Buy
8-day EMA: 52.87 Sell
20-day EMA: 52.74 Sell
50-day EMA: 51.49 Buy
200-day EMA: 48.38 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.77 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

MoonLake Immunotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):